The Experts below are selected from a list of 2679 Experts worldwide ranked by ideXlab platform
Hans H Schild - One of the best experts on this subject based on the ideXlab platform.
-
transrenal ureteral occlusion using the amplatzer Vascular Plug ii a new interventional treatment option for lower urinary tract fistulas
CardioVascular and Interventional Radiology, 2014Co-Authors: Claus Christian Pieper, Carsten H Meyer, Stefan Hauser, K Wilhelm, Hans H SchildAbstract:Purpose This study was designed to evaluate the results of a novel technique for transrenal ureteral occlusion using an Amplatzer Vascular Plug (AVP) II in patients with urinary fistulas.
-
transrenal ureter occlusion with an amplatzer Vascular Plug
Journal of Vascular and Interventional Radiology, 2009Co-Authors: Hans H Schild, Carsten H Meyer, Markus Mohlenbroch, Stefan C Mueller, Birgit Simon, Christiane K KuhlAbstract:The Amplatzer Vascular Plug has been used as an embolic device in a variety of cardioVascular interventions. The present report describes successful transrenal ureter occlusion with an Amplatzer Plug inserted into an excised latex cover. The procedure led to immediate ureter occlusion in a patient with vesicovaginal fistula. Further investigation into the use of this technique for ureteral occlusion is warranted.
Kyubo Sung - One of the best experts on this subject based on the ideXlab platform.
-
gastric varices and hepatic encephalopathy treatment with Vascular Plug and gelatin sponge assisted retrograde transvenous obliteration a primary report
Radiology, 2013Co-Authors: Dong Il Gwon, Giyoung Ko, Hyunki Yoon, Kyubo Sung, Ji Hoon Shin, Heung Kyu Ko, Hoyoung SongAbstract:Vascular Plug–assisted retrograde transvenous obliteration is technically simple and safe and seems to be clinically effective for the treatment of gastric varices and hepatic encephalopathy.
-
Preoperative portal vein embolization using an amplatzer Vascular Plug
European Radiology, 2009Co-Authors: Giyoung Ko, Dong Il Gwon, Hyunki Yoon, Kyubo SungAbstract:The purpose was to evaluate the safety and efficacy of preoperative portal vein embolization (PVE) using an Amplatzer Vascular Plug (AVP). Forty-one patients who underwent PVE using gelatin sponge particles and the AVP were enrolled. The right portal branches were embolized using gelatin sponges (1–8 mm^3) through a 5-F catheter, and the AVP was deployed at the first- or second-order right portal vein. Technical success and complications, recanalization, and changes of total estimated liver volumes (TELV), future liver remnant (FLR), and FLR/TELV were evaluated. Follow-up CT performed 6–43 days (median, 16 days) after PVE was used to evaluate volume parameters. PVE was technically successful in 40 of 41 patients. Major complications occurred in two patients, with one each having extensive portal vein thrombosis and liver abscess. Partial recanalization of the occluded portal vein was seen in one patient. The mean FLR volume (653 ± 174 ml vs. 532 ± 154 ml, p
Sara Seitun - One of the best experts on this subject based on the ideXlab platform.
-
the amplatzer Vascular Plug 4 preliminary experience
CardioVascular and Interventional Radiology, 2010Co-Authors: Carlo Ferro, Francesco Petrocelli, Umberto G Rossi, Giulio Bovio, Sara SeitunAbstract:The purpose of this communication is to describe our preliminary experience with the AMPLATZER Vascular Plug 4 (AVP 4) in peripheral Vascular embolization. The AVP 4 was used for peripheral Vascular embolization in five patients with renal pseudoaneurysm (n = 2), postsurgical peritoneal bleeding (n = 1), posttraumatic gluteal hemorrhage (n = 1), and intercostal pseudoaneurysm (n = 1). Occlusion time was recorded. Patients were followed up clinically and by imaging for 1 month after the procedure. All treated vessels or Vascular abnormalities were successfully occluded within 3 min for low-flow circulation and over 8 min for high-flow circulation. At 1-month follow-up, all patients were symptom-free. All deployed devices remained in the original locations and desirable configurations. In conclusion, the AVP 4 seems to be safe and effective for occluding peripheral vessels and Vascular abnormalities. Because of its compatibility with 0.038–in. catheters, it can be deployed through a diagnostic catheter following angiography without exchanging a sheath or guiding catheter. Compared with the previous generation of Vascular Plugs, the AVP 4 allows for faster procedure times and decreased exposure to radiation.
-
Vascular percutaneous transcatheter embolisation with a new device amplatzer Vascular Plug
Radiologia Medica, 2007Co-Authors: Carlo Ferro, Francesco Petrocelli, Umberto G Rossi, Giulio Bovio, Mh Dahmane, Sara SeitunAbstract:Purpose. The aim of this study was to evaluate the effectiveness of the new Amplatzer Vascular Plug (AVP) for the occlusion of Vascular abnormalities and peripheral vessels, especially those with a large diameter.
Candido Martin Luengo - One of the best experts on this subject based on the ideXlab platform.
-
paravalvular leak closure with the amplatzer Vascular Plug iii device immediate and short term results
Revista Espanola De Cardiologia, 2014Co-Authors: Ignacio Cruzgonzalez, Juan Carlos Ramamerchan, Antonio Arribasjimenez, Javier Rodriguezcollado, Javier Martinmoreiras, Manuel Casconbueno, Candido Martin LuengoAbstract:Abstract Introduction and objectives Percutaneous paravalvular leak closure is a complex procedure with varying success rates; the lack of closure devices specifically designed for this purpose has hampered this technique. The characteristics of the Amplatzer Vascular Plug III appear to be well suited for paravalvular leak closures; however, the available data are limited to case reports or small series of patients. The aim of this study was to analyze the feasibility and efficacy of paravalvular leak with this device. Methods The immediate and 90-day safety and efficacy of mitral and aortic paravalvular leak closures performed with this device at our hospital were analyzed. Results Percutaneous repair of 34 paravalvular leaks (27 mitral, 7 aortic) was attempted in 33 patients. The device was successfully implanted in 93.9% (in 2 patients, a second planned procedure was needed), and successful closure (defined as regurgitation reduction ≥ 1 grade) was achieved in 90.9% of patients. Complications included emergency surgery due to disc interference (n = 1) and blood transfusion (n = 3). There were no reports of procedure-related death, myocardial infarction, or stroke. At 90 days, survival was 100%, and 90.3% of patients showed significant clinical improvement; 4 patients developed Vascular complications (pseudoaneurysm). Conclusions Mitral and aortic paravalvular leak closure with the Amplatzer Vascular Plug III is feasible and safe, with high clinical and echocardiographic success rates.
Afshin Gangi - One of the best experts on this subject based on the ideXlab platform.
-
pulmonary arteriovenous malformations embolized using a micro Vascular Plug system technical note on a preliminary experience
CardioVascular and Interventional Radiology, 2017Co-Authors: Emanuele Boatta, Roberto Luigi Cazzato, Christine Jahn, Matthieu Canuet, Julien Garnon, Nitin Ramamurthy, Afshin GangiAbstract:AIM To report our preliminary experience using a Micro Vascular Plug (MVP) deployed through a 2.8Fr micro-catheter for the treatment of pulmonary arteriovenous malformations (PAVMs) in a cohort of patients affected by Hereditary Haemorrhagic Telangiectasia (HHT).
